(19)
(11) EP 1 225 909 A2

(12)

(88) Date of publication A3:
10.05.2002

(43) Date of publication:
31.07.2002 Bulletin 2002/31

(21) Application number: 00968465.5

(22) Date of filing: 29.09.2000
(51) International Patent Classification (IPC)7A61K 38/18, C07K 14/50, A61K 39/395, C07K 16/22
(86) International application number:
PCT/US0026/689
(87) International publication number:
WO 0125/271 (12.04.2001 Gazette 2001/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 02.10.1999 US 157103 P

(71) Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Rockville, MD 20852-3804 (US)

(72) Inventors:
  • HANADA, Ken-Ichi
    Rockville, MD 20852 (US)
  • YANG, James, C.
    Silver Spring, MD 20904 (US)

(74) Representative: Gowshall, Jonathan Vallance 
FORRESTER & BOEHMERTPettenkoferstrasse 20-22
80336 München
80336 München (DE)

   


(54) FIBROBLAST GROWTH FACTOR-5 (FGF-5) IS A TUMOR ASSOCIATED T-CELL ANTIGEN